Corporate Announcement QIAGEN receives U.S. FDA emergency use authorization for rapid portable SARS-CoV-2 antigen test Ellume August 10, 2021
Corporate Announcement Alaska Airlines Partners with AZOVA to Provide Ellume COVID-19 Home Tests & Video Observation for Safe, Healthy Travel Ellume July 1, 2021
Corporate Announcement Media New rapid COVID testing options coming to Delta; Purchase and pack for smooth U.S. re-entry Ellume June 24, 2021
Corporate Announcement Ellume establishes flagship U.S. manufacturing facility in Maryland Ellume May 10, 2021
Corporate Announcement Over-the-counter COVID-19 testing now available at CVS Pharmacy Ellume April 20, 2021
Corporate Announcement Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test Ellume March 10, 2021
Corporate Announcement Ellume Announces $231.8 Million Agreement with the U.S. Government Ellume February 1, 2021
Corporate Announcement FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test Ellume December 15, 2020
Corporate Announcement Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study Ellume December 10, 2020
Corporate Announcement Ellume awarded US$30M from US National Institutes of Health RADx initiative to accelerate development of rapid COVID-19 diagnostics Ellume October 7, 2020
Corporate Announcement Ellume announces high-performance test for active COVID-19 infection Ellume September 10, 2020
Corporate Announcement Ellume announces global partnership with QIAGEN for COVID-19 diagnosis Ellume August 25, 2020
Corporate Announcement Ellume appoints Joanne Moss to its Board as Non-executive Director Ellume November 12, 2019
Corporate Announcement Ellume announces another global partnership with QIAGEN on the detection of tuberculosis Ellume January 8, 2019